Results 1–20 of 60 for liothyronine

Written Answers — Department of Health and Social Care: Liothyronine (24 Feb 2020)

Lord Hunt of Kings Heath: ...on 7 February; and in particular the reported failure by Clinical Commissioning Groups to follow NHS England’s Regional Medicines Optimisation Committee’s revised Guidance–Prescribing of Liothyronine, published in July 2019.

Written Answers — Department of Health and Social Care: Liothyronine (12 Feb 2020)

Lord Hunt of Kings Heath: ...what assessment they have made of the operation of data protection legislation in respect of Clinical Commissioning Groups asking to see patients' personal health data when reviewing the use of liothyronine for the purposes of cost cutting.

Written Answers — Department of Health and Social Care: Medical Treatments: Finance (5 Nov 2019)

Lord Hunt of Kings Heath: To ask Her Majesty's Government whether Individual Funding Requests are intended to be used for rationing access to NHS treatments, such as liothyronine, where there is a recognised cohort of patients.

Written Answers — Department of Health and Social Care: Liothyronine (5 Nov 2019)

Lord Hunt of Kings Heath: To ask Her Majesty's Government how many Individual Funding Requests have been received for treatment with liothyronine since the start of the Low Priority Prescribing Project Programme in 2017.

Written Answers — Department of Health and Social Care: Liothyronine: West Midlands (4 Nov 2019)

Lord Hunt of Kings Heath: ...Majesty's Government what action can be taken by thyroid patents who in raising concerns about the Birmingham and Solihull Clinical Commissioning Group's (CCG) refusal to allow the prescription of liothyronine, were told by that CCG to raise the issue with NHS England only to be told by NHS England to raise the matter with that CCG.

Written Answers — Department of Health and Social Care: Liothyronine (4 Nov 2019)

Lord Hunt of Kings Heath: To ask Her Majesty's Government what action they are taking to ensure that the updated prescribing guidance for liothyronine issued by the South Regional Medicines Optimisation Committee in July is followed by all Clinical Commissioning Groups.

Written Answers — Department of Health and Social Care: Liothyronine (4 Nov 2019)

Lord Hunt of Kings Heath: To ask Her Majesty's Government what action they propose to take in relation to thyroid patients who, having previously had successful treatment on dosages of 20mcg and above of liothyronine, are now facing a restriction on the dosage.

Written Answers — Department of Health and Social Care: Liothyronine: Merseyside (4 Nov 2019)

Lord Hunt of Kings Heath: To ask Her Majesty's Government what further proof of eligibility for treatment with liothyronine is required for those patients, in Clinical Commissioning Groups (CCG) who are members of the Pan Mersey Area Prescribing Committee, for whom an endocrinologist has confirmed levothyroxine treatment has not been suitable and has recommended they are prescribed liothyronine, and where the CCG is...

Written Answers — Department of Health and Social Care: Liothyronine: West Midlands (4 Nov 2019)

Lord Hunt of Kings Heath: To ask Her Majesty's Government what assessment they have made, if any, of whether the Birmingham and Solihull Clinical Commissioning Group is following the updated prescribing guidance for liothyronine issued by the South Regional Medicines Optimisation Committee in July; and what action they are taking to ensure the guidance is being followed.

Written Answers — Department of Health and Social Care: Liothyronine (4 Nov 2019)

Lord Hunt of Kings Heath: To ask Her Majesty's Government what price to the NHS liothyronine would need to fall below in order for the restriction on its prescription to be lifted.

Written Answers — Department of Health and Social Care: Liothyronine (9 Jul 2019)

Seema Malhotra: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the value for money of prescribing Liothyronine (T3) on the NHS.

Written Answers — Department of Health and Social Care: Liothyronine (5 Mar 2019)

John Baron: To ask the Secretary of State for Health and Social Care, what plans the Government has to ensure NHS patients throughout England continue to receive liothyronine after recent price increase in the cost of that drug to the NHS.

Written Answers — Department of Health and Social Care: Liothyronine (27 Feb 2019)

Lord Hunt of Kings Heath: To ask Her Majesty's Government what steps they will take to prevent any harm to thyroid patients who require liothyronine and who are unable to secure funding for such treatment by Clinical Commissioning Groups because of the cost of this medicine set by the three UK licence holders.

Written Answers — Department of Health and Social Care: Liothyronine (11 Feb 2019)

Lord Hunt of Kings Heath: To ask Her Majesty's Government what discussions they have had, or intend to have, with NHS England on ensuring Liothyronine (T3) is prescribed in accordance with NICE guidelines.

Written Answers — Department of Health and Social Care: Liothyronine (11 Feb 2019)

Lord Hunt of Kings Heath: To ask Her Majesty's Government what steps they are taking to ensure that Liothyronine (T3) is purchased at a cost in line with other EU countries.

Written Answers — Department of Health and Social Care: University Hospitals Bristol NHS Foundation Trust: Liothyronine (22 Jan 2019)

Lord Hunt of Kings Heath: To ask Her Majesty's Government what action they plan to take to lift the ban on the prescription of liothyronine (T3) by University Hospital Bristol in contradiction of the advice given by NHS England.

Written Answers — Department of Health and Social Care: Liothyronine: Prices (15 Jan 2019)

Jim Shannon: To ask the Secretary of State for Health and Social Care, what discussions he has had with pharmaceutical companies on reducing the cost of the drug liothyronine.

Written Answers — Department of Health and Social Care: Liothyronine (20 Dec 2018)

Lord Hunt of Kings Heath: To ask Her Majesty's Government what action they are taking to negotiate a reduction of the cost of liothyronine (T3) for use in primary care.

Scottish Parliament: Thyroid and Adrenal Testing, Diagnosis and Treatment (4 Dec 2018)

Elaine Smith: ...important aspect for those needing it to survive: “The Scottish Government’s position is that treatment for Hypothyroidism in Scotland should be consistent with the BTA guidance in relation to Liothyronine (T3) and clinicians in Scotland can prescribe T3 where it is safe and clinically appropriate, on the advice of a consultant in endocrinology.” The minister backed that up in his...

Scottish Parliament: Women’s Health (Obesity) (27 Sep 2018)

Elaine Smith: ...disorders? Does she agree that it is unacceptable for any Scottish national health service board to refuse patients, particularly those under the care of an endocrinologist, their prescriptions for liothyronine medication, as currently happens? Will she ask the Cabinet Secretary for Health and Sport to intervene to ensure that my constituents and other thyroid sufferers are not stopped by...


1 2 3 > >>

Create an alert

Did you find what you were looking for?

Advanced search

Find this exact word or phrase

You can also do this from the main search box by putting exact words in quotes: like "cycling" or "hutton report"

By default, we show words related to your search term, like “cycle” and “cycles” in a search for cycling. Putting the word in quotes, like "cycling", will stop this.

Excluding these words

You can also do this from the main search box by putting a minus sign before words you don’t want: like hunting -fox

We also support a bunch of boolean search modifiers, like AND and NEAR, for precise searching.

Date range

to

You can give a start date, an end date, or both to restrict results to a particular date range. A missing end date implies the current date, and a missing start date implies the oldest date we have in the system. Dates can be entered in any format you wish, e.g. 3rd March 2007 or 17/10/1989

Person

Enter a name here to restrict results to contributions only by that person.

Section

Restrict results to a particular parliament or assembly that we cover (e.g. the Scottish Parliament), or a particular type of data within an institution, such as Commons Written Answers.

Column

If you know the actual Hansard column number of the information you are interested in (perhaps you’re looking up a paper reference), you can restrict results to that; you can also use column:123 in the main search box.